Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

550 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group.
Provenzano E, Bossuyt V, Viale G, Cameron D, Badve S, Denkert C, MacGrogan G, Penault-Llorca F, Boughey J, Curigliano G, Dixon JM, Esserman L, Fastner G, Kuehn T, Peintinger F, von Minckwitz G, White J, Yang W, Symmans WF; Residual Disease Characterization Working Group of the Breast International Group-North American Breast Cancer Group Collaboration. Provenzano E, et al. Among authors: dixon jm. Mod Pathol. 2015 Sep;28(9):1185-201. doi: 10.1038/modpathol.2015.74. Epub 2015 Jul 24. Mod Pathol. 2015. PMID: 26205180 Free article.
Postcode prescribing is alive and well in Scotland.
Cameron D, Dixon JM. Cameron D, et al. Among authors: dixon jm. BMJ. 2002 Jul 13;325(7355):101A. doi: 10.1136/bmj.325.7355.101/a. BMJ. 2002. PMID: 12114247 Free PMC article. No abstract available.
Neoadjuvant endocrine therapy models.
Murray J, Miller WR, Dixon JM. Murray J, et al. Among authors: dixon jm. Methods Mol Med. 2006;120:489-502. doi: 10.1385/1-59259-969-9:489. Methods Mol Med. 2006. PMID: 16491621
Neoadjuvant use of endocrine therapy in breast cancer.
Macaskill EJ, Dixon JM. Macaskill EJ, et al. Among authors: dixon jm. Breast J. 2007 May-Jun;13(3):243-50. doi: 10.1111/j.1524-4741.2007.00417.x. Breast J. 2007. PMID: 17461898 Review.
Increase in response rate by prolonged treatment with neoadjuvant letrozole.
Dixon JM, Renshaw L, Macaskill EJ, Young O, Murray J, Cameron D, Kerr GR, Evans DB, Miller WR. Dixon JM, et al. Breast Cancer Res Treat. 2009 Jan;113(1):145-51. doi: 10.1007/s10549-008-9915-6. Epub 2008 Feb 9. Breast Cancer Res Treat. 2009. PMID: 18264759 Clinical Trial.
Impact of screening and risk factors for local recurrence and survival after conservative surgery and radiotherapy for early breast cancer: results from a large series with long-term follow-up.
Kunkler IH, Kerr GR, Thomas JS, Jack WJ, Bartlett JM, Pedersen HC, Cameron DA, Dixon JM, Chetty U; Edinburgh Breast Group. Kunkler IH, et al. Among authors: dixon jm. Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):829-38. doi: 10.1016/j.ijrobp.2011.08.018. Epub 2011 Dec 22. Int J Radiat Oncol Biol Phys. 2012. PMID: 22197227
Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer research.
Moossdorff M, van Roozendaal LM, Strobbe LJ, Aebi S, Cameron DA, Dixon JM, Giuliano AE, Haffty BG, Hickey BE, Hudis CA, Klimberg VS, Koczwara B, Kühn T, Lippman ME, Lucci A, Piccart M, Smith BD, Tjan-Heijnen VC, van de Velde CJ, Van Zee KJ, Vermorken JB, Viale G, Voogd AC, Wapnir IL, White JR, Smidt ML. Moossdorff M, et al. Among authors: dixon jm. J Natl Cancer Inst. 2014 Nov 7;106(12):dju288. doi: 10.1093/jnci/dju288. Print 2014 Dec. J Natl Cancer Inst. 2014. PMID: 25381395 Free PMC article.
550 results